Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models

• Mathias Dahlmann,
• Guido Gambara,
• Bernadette Brzezicha,
• Oliver Popp,
• Eva Pachmayr,
• Lena Wedeken,
• Alina Pflaume,
• Margarita Mokritzkij,
• Safak Gül-Klein,
• Andreas Brandl,
• Caroline Schweiger-Eisbacher,
• Philipp Mertins,
• Jens Hoffmann,
• Ulrich Keilholz,
• Wolfgang Walther,
• Christian Regenbrecht,
• Beate Rau,
• Ulrike Stein

Affiliations

Mathias Dahlmann

Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité - University Medicine Berlin, and Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association

Guido Gambara

German Cancer Consortium (DKTK)

Bernadette Brzezicha

EPO GmbH Berlin-Buch

Oliver Popp

Proteomics Platform, Max-Delbrück-Center for Molecular Medicine and Berlin Institute of Health

Eva Pachmayr

Department of Surgery, Charité - University Medicine Berlin

Lena Wedeken

CELLphenomics GmbH

Alina Pflaume

CELLphenomics GmbH

Margarita Mokritzkij

Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité - University Medicine Berlin, and Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association

Safak Gül-Klein

Department of Surgery, Charité - University Medicine Berlin

Andreas Brandl

Department of Surgery, Charité - University Medicine Berlin

Caroline Schweiger-Eisbacher

German Cancer Consortium (DKTK)

Philipp Mertins

Proteomics Platform, Max-Delbrück-Center for Molecular Medicine and Berlin Institute of Health

Jens Hoffmann

EPO GmbH Berlin-Buch

Ulrich Keilholz

German Cancer Consortium (DKTK)

Wolfgang Walther

Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité - University Medicine Berlin, and Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association

Christian Regenbrecht

CELLphenomics GmbH

Beate Rau

Department of Surgery, Charité - University Medicine Berlin

Ulrike Stein

Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité - University Medicine Berlin, and Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association